155 related articles for article (PubMed ID: 19572064)
1. Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: fibrinogen Mannheim V.
Dempfle CE; George PM; Borggrefe M; Neumaier M; Brennan SO
Thromb Haemost; 2009 Jul; 102(1):29-34. PubMed ID: 19572064
[TBL] [Abstract][Full Text] [Related]
2. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen heterogeneity in homozygous plasminogen deficiency type I: further evidence that plasmin is not involved in formation of LMW- and LMW'-fibrinogen.
Dempfle CE; Pfitzner SA; Schott D; Niessen KH; Heene DL
Thromb Haemost; 1997 May; 77(5):879-83. PubMed ID: 9184396
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M
Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658
[TBL] [Abstract][Full Text] [Related]
6. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).
Brennan SO; Hammonds B; George PM
J Clin Invest; 1995 Dec; 96(6):2854-8. PubMed ID: 8675656
[TBL] [Abstract][Full Text] [Related]
7. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene.
Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N
Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469
[TBL] [Abstract][Full Text] [Related]
8. Novel fibrinogen truncation with deletion of Bbeta chain residues 440-461 causes hypofibrinogenaemia.
Homer VM; Brennan SO; Ockelford P; George PM
Thromb Haemost; 2002 Sep; 88(3):427-31. PubMed ID: 12353071
[TBL] [Abstract][Full Text] [Related]
9. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy.
Miesbach W; Galanakis D; Scharrer I
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):366-70. PubMed ID: 19357502
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
Bolliger-Stucki B; Lord ST; Furlan M
Blood; 2001 Jul; 98(2):351-7. PubMed ID: 11435303
[TBL] [Abstract][Full Text] [Related]
11. Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the gamma Ala82Gly mutation.
Zdziarska J; Undas A; Basa J; Iwaniec T; Skotnicki AB; de Moerloose P; Neerman-Arbez M
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):374-6. PubMed ID: 19300242
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution.
Steinmann C; Bögli C; Jungo M; Lämmle B; Heinemann G; Wermuth B; Redaelli R; Baudo F; Furlan M
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):463-71. PubMed ID: 7841300
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA).
Koopman J; Haverkate F; Grimbergen J; Egbring R; Lord ST
Blood; 1992 Oct; 80(8):1972-9. PubMed ID: 1391954
[TBL] [Abstract][Full Text] [Related]
15. Abnormal fibrinogens IJmuiden (B beta Arg14----Cys) and Nijmegen (B beta Arg44----Cys) form disulfide-linked fibrinogen-albumin complexes.
Koopman J; Haverkate F; Grimbergen J; Engesser L; Nováková I; Kerst AF; Lord ST
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3478-82. PubMed ID: 1565641
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T
Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation.
de Raucourt E; de Mazancourt P; Maghzal GJ; Brennan SO; Mosesson MW
Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237
[TBL] [Abstract][Full Text] [Related]
18. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
[TBL] [Abstract][Full Text] [Related]
19. A novel fibrinogen variant--Liberec: dysfibrinogenaemia associated with gamma Tyr262Cys substitution.
Kotlín R; Sobotková A; Suttnar J; Salaj P; Walterová L; Riedel T; Reicheltová Z; Dyr JE
Eur J Haematol; 2008 Aug; 81(2):123-9. PubMed ID: 18485115
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen New Britain: characterization of an A alpha Arg 16-->His variant human fibrinogen.
Webb CD; Hantgan RR; Byeff PD; Owen J
Blood Coagul Fibrinolysis; 1994 Apr; 5(2):233-8. PubMed ID: 8054455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]